We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Zynerba Pharmaceuticals, Inc in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $16.2K → $0 (-$16.2K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
–
Holders Change
-1
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BRWA
B. Riley Wealth Advisors
Florida
-$16.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
BRWA
1
B. Riley Wealth Advisors
Florida
– -$16.2K -12,732 Closed

ZYNE Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q2 2024, worth a combined $0 — down 100% from $16.2K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ZYNE and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $16.2K sold.

  • 0 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q2 2024, down from 1 in Q1 2024.
  • Funds reported $0 of Zynerba Pharmaceuticals, Inc stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Zynerba Pharmaceuticals, Inc positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q2 2024 was B. Riley Wealth Advisors, an estimated $16.2K sold.

Based on aggregated 13F filings for Q2 2024.